Imexpharm Corp (IMP) — Financial Flexibility Index
Imexpharm Corp (IMP) has a Financial Flexibility Index of 0.25x as of March 2026. Free cash flow of ₫111.28 Billion (operating CF ₫103.49 Billion minus capex ₫7.79 Billion) represents 0% of total liabilities (₫442.31 Billion). Also explore net asset momentum of Imexpharm Corp to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Imexpharm Corp Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Imexpharm Corp across 7 annual periods. Check how strategically is Imexpharm Corp's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Imexpharm Corp (2019–2025)
Year-by-year free cash flow to debt coverage for Imexpharm Corp. For the full company profile including market capitalisation, see Imexpharm Corp market capitalisation.
| Year | Flexibility Index | Free Cash Flow (VND) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | ₫81.05 Billion | ₫54.17 Billion | ₫476.11 Billion | ▼ -82.5% |
| 2024 | 0.97x | ₫313.04 Billion | ₫216.27 Billion | ₫321.66 Billion | ▲ +1225.1% |
| 2023 | 0.07x | ₫22.62 Billion | ₫-40.47 Billion | ₫308.04 Billion | ▼ -94.1% |
| 2022 | 1.25x | ₫477.96 Billion | ₫378.60 Billion | ₫382.50 Billion | ▲ +117.3% |
| 2021 | 0.58x | ₫287.74 Billion | ₫234.88 Billion | ₫500.29 Billion | ▲ +29.3% |
| 2020 | 0.44x | ₫162.84 Billion | ₫73.15 Billion | ₫365.97 Billion | ▼ -35.1% |
| 2019 | 0.69x | ₫197.72 Billion | ₫66.59 Billion | ₫288.29 Billion | — |